Healthy Returns: Brain implant company Paradromics launches patient registry ahead of human trial

Brain implant company Paradromics is preparing for human trials, while President Biden's poor debate performance affected health-care stocks.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.